MetaCap

Who Owns Lycia Therapeutics Stock?

NASDAQ: LYCAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

33.07+1.30 (+4.09%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
46.67%
Institutional holders
6
  • Institutions 46.7%
  • Insiders 9.4%
  • Public and other 43.9%

Who owns Lycia Therapeutics stock?

Institutional investors own about 46.7% of Lycia Therapeutics's shares, spread across 6 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 9.41% of LYCA.

Summary generated from market data by MetaCap's automated system. Methodology

Frequently asked questions

What percentage of Lycia Therapeutics is owned by institutions?

Institutions own about 46.7% of LYCA shares and 51.5% of the public float.

How much of Lycia Therapeutics do insiders own?

Insiders, such as officers and directors, own about 9.41% of LYCA shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related